Antonio Fagundes Selected Research

Troponin

1/2022

Biomarker Prediction of Complex Coronary Revascularization Procedures in the FOURIER Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Antonio Fagundes Research Topics

Disease

2	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 01/2021
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 01/2021
1	Embolism (Embolus) 01/2023
1	Hemorrhage 01/2023
1	Stroke (Strokes) 01/2023
1	Atherosclerosis 01/2022
1	Inflammation (Inflammations) 01/2022
1	Myocardial Infarction 01/2022
1	Respiratory Insufficiency (Respiratory Failure) 01/2022
1	Shock 01/2022
1	COVID-19 01/2022
1	Critical Illness (Critically Ill) 01/2022
1	Heart Failure 01/2022
1	Coronary Disease (Coronary Heart Disease) 01/2021

Drug/Important Bio-Agent (IBA)

2	evolocumabIBA 01/2022 - 01/2021
2	Proprotein Convertase 9IBA 01/2022 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2022
1	edoxabanIBA 01/2023
1	omega-Chloroacetophenone (Mace)IBA 01/2023
1	TroponinIBA 01/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021

Therapy/Procedure

2	Therapeutics 01/2022 - 01/2021
1	Percutaneous Coronary Intervention 01/2022
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2022
1	Critical Care (Surgical Intensive Care) 01/2022